CASES DESCRIPTION: We report two cases of drug rash with eosinophilia and systemic symptoms (DRESS) associated with the use of carbamazepine and phenytoin in Brazilian boys tested for human leukocyte antigen (HLA) class I and II alleles. The clinical manifestations were similar: a maculopapular eruption progressing to exfoliative erythroderma, fever, and lymphadenopathy. Leukocytosis, atypical lymphocytes, and liver injury were also observed. Assessment of causality using the Naranjo algorithm established a "probable" relationship (score 6) in both cases. Case 1 patient presented the following results of HLA typing: HLA-A*02,29 B*44,50 C*06,16 DRB1*01,07 DQA1*01,02. Case 2 patient presented the following results of HLA typing: HLAA*23,24 B*39,53 C*04,07 DRB1*04,08 DQA1*03,05 DQB1*03,03. CONCLUSION: Neither of the cases reported here presented HLA typing similar to that strongly associated with the occurrence of DRESS in Asian or European patients.
CASES DESCRIPTION: We report two cases of drug rash with eosinophilia and systemic symptoms (DRESS) associated with the use of carbamazepine and phenytoin in Brazilian boys tested for human leukocyte antigen (HLA) class I and II alleles. The clinical manifestations were similar: a maculopapular eruption progressing to exfoliative erythroderma, fever, and lymphadenopathy. Leukocytosis, atypical lymphocytes, and liver injury were also observed. Assessment of causality using the Naranjo algorithm established a "probable" relationship (score 6) in both cases. Case 1 patient presented the following results of HLA typing: HLA-A*02,29 B*44,50 C*06,16 DRB1*01,07 DQA1*01,02. Case 2 patient presented the following results of HLA typing: HLAA*23,24 B*39,53 C*04,07 DRB1*04,08 DQA1*03,05 DQB1*03,03. CONCLUSION: Neither of the cases reported here presented HLA typing similar to that strongly associated with the occurrence of DRESS in Asian or European patients.
Authors: C M Probst; E P Bompeixe; N F Pereira; M M de O Dalalio; J E Visentainer; L T Tsuneto; M L Petzl-Erler Journal: Hum Biol Date: 2000-08 Impact factor: 0.553
Authors: Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann Journal: Drug Saf Date: 2006 Impact factor: 5.606
Authors: Mandvi Bharadwaj; Patricia Illing; Alex Theodossis; Anthony W Purcell; Jamie Rossjohn; James McCluskey Journal: Annu Rev Pharmacol Toxicol Date: 2011-10-17 Impact factor: 13.820
Authors: Ana Alfirevic; Andrea L Jorgensen; Paula R Williamson; David W Chadwick; B Kevin Park; Munir Pirmohamed Journal: Pharmacogenomics Date: 2006-09 Impact factor: 2.533
Authors: Paulo Ricardo Criado; Roberta Fachini Jardim Criado; João de Magalhães Avancini; Claudia Giuli Santi Journal: An Bras Dermatol Date: 2012 May-Jun Impact factor: 1.896